A股異動丨中文在線尾盤逼近升停 股價創逾3個月新高 市值逼近200億
中文在線(300364.SZ)午後逆勢走高,尾盤強勢拉昇一度逼近升停,股價高見26.98元創2月28日以來逾3個月新高,市值逼近200億元關口。消息面上,中文在線宣佈推出面向國際創作者的AI寫作平台——逍遙海外作者平台(XIAOYAO)。平台依託中文在線自研的“逍遙大模型”,聚焦英文小説賽道,覆蓋創作全過程,包括構思生成、語言潤色、邏輯修復、角色管理、情節續寫等多個維度。有分析指出,該平台支持中英雙語創作,降低英文寫作門檻,並打通簽約、全球分發及收益分成機制,XIAOYAO的推出將豐富中文在線海外內容生態,反哺短劇、漫劇等衍生業務,加速全球化“技術+內容”戰略佈局。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.